Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

NCT: NCT07211126 · RECRUITING

NCT IDNCT07211126
StatusRECRUITING
Start Date2026-03-03
Completion2027-12

Brief Summary

This post-market surveillance study is primarily designed to demonstrate the ongoing safety of the Control-IQ system, the ongoing performance of glycemic control and quality of life with Control-IQ system use, and the rate of use of the Control-IQ system. The system will be assessed in all approved populations during the first 12 months of use.

Frequently Asked Questions

What is The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France?

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France is a clinical trial registered under NCT07211126. Current status: RECRUITING.

What is the status of NCT07211126?

The current status of NCT07211126 (The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France) is: RECRUITING.

When did The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France start?

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France started on 2026-03-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑